News
Becton, Dickinson (NYSE:BDX) declares $1.04/share quarterly dividend, in line with previous. Forward yield 2.29% Payable Sept. 30; for shareholders of record Sept. 8; ex-div Sept. 8. See BDX Dividend ...
Waters said it reached a deal to buy the Biosciences & Diagnostic Solutions business of Becton Dickinson for around $17.5 ...
This was the stock's second consecutive day of losses.
Becton, Dickinson's divestment enhances focus, reduces leverage, funds buybacks, and unlocks value. Read more about the M&A ...
Life sciences firm Waters will take on $4 billion in debt, and issue 39.2% of its shares to Becton Dickinson shareholders.
Lab equipment maker Waters Corp on Monday said it will buy a bioscience and diagnostics unit spun off from medtech provider ...
Explore more
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $1.04 per common share, ...
Milford-based biotech company Waters Corp. will merge with Becton, Dickinson and Co.’s biosciences an diagnostic solutions ...
Medical analysis equipment maker Waters is combining with a unit of Becton Dickinson in a complex spin-merge. At a discount ...
Universal Health Realty's dividend has been hiked annually for four decades. That's a pretty good streak, even though it ...
Becton Dickinson & Co. closed 29.02% below its 52-week high of $251.99, which the company reached on February 3rd.
Becton Dickinson said production of its recently approved rapid test for the coronavirus strain Covid-19 will ramp up to 12 million tests per month by the end of February 2021.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results